Rory co-founded Royalty Pharma in 1996 and assumed the role of Chairman of the Investment Committee from 2003 until 2020. Rory is the founder & CEO of Syntax & Locus Analytics. Previously, Rory was President of Biomatrix. Rory serves or has served on several boards including Fibrogen, Cibus, Sugen, Intra-cellular Therapies and Biomatrix. Rory has a BA from Middlebury College and an MBA from Columbia University.